Important Disclosure Information. Read Before Proceeding.
Companies
Neuralink
Neuralink
San Francisco, CA
Founded 2016
Healthcare
Neuralink is a developer of brain-machine interfaces, building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.
neuralink.com|X (Twitter)|LinkedIn|Crunchbase
Last Round Valuation
$9.65B
Last Round Share Price
$ XX.XY
Total Funding
$1.3B
Last Round
Series E
Neuralink
$247.92
Fund Marks
1M
3M
YTD
1Y
2Y
MAX
Powered by Caplight

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

Mutual Funds

Nothing here
Let us know if we are missing anything

News

Neuralink Prepares for Blindsight Implant Testing, No Revenue Disclosed thumbnail image
05/28/2026
Neuralink Prepares for Blindsight Implant Testing, No Revenue Disclosed
Neuralink's advancement into blindsight implant testing signals a pivotal shift in neurotechnology, potentially attracting significant investment interest despite the absence of disclosed revenue, as it positions itself at the forefront of a burgeoning market for brain-computer interfaces.
The Times of IndiaChristian Post
Neuralink Advances Neurotechnology with 21 Patient Implants thumbnail image
05/24/2026
Neuralink Advances Neurotechnology with 21 Patient Implants
Neuralink's successful implantation in 21 patients not only advances neurotechnology but also positions the company as a frontrunner in a burgeoning market, potentially attracting significant investment and partnerships in the healthcare and tech sectors.
AOL.comKTXSThe Free PressStartupHub.aiThe News International
Neuralink Valued at Nearly $9 Billion thumbnail image
05/16/2026
Neuralink Valued at Nearly $9 Billion
Neuralink's nearly $9 billion valuation underscores investor confidence in the potential of brain-computer interfaces, positioning the company at the forefront of a transformative sector that could redefine healthcare and technology integration.
Tech TimesWIONTech Times

Research

Neuralink One-Pager
Synchron One-Pager
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Is trading on Augment safe and legitimate?
Are orders posted anonymously?
How do I know what price to buy or sell shares?
How do Augment fees work?
How can I get notified when there are new interested buyers of my shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
What size transactions does Augment support?
How do I know if an order is created by a broker or a direct buyer or user?
What is the typical process of selling shares?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.